} //--> Pan American Health Organization Improving the Health of the Peoples of the Americas Homepage | Data | Topics | Resources | Online Bookstore | About PAHO Search Vol. 17, No. 1 March 1996 INTRODUCTION OF NEW VACCINES IN THE NATIONAL VACCINATION PROGRAMS Introduction of New Vaccines Hepatitis B Vaccine MMR Vaccine (Measles, Mumps, Rubella) Haemophilus Influenzae B Vaccine (Hib) Typhoide Fever Vaccine Yellow Fever Vaccine Meningococcal Meningitis Vaccine Pneumococcus Vaccine Considerations for Including a New Vaccine The introduction of new or improved vaccines in national vaccination programs should be preceded by a determination of the intervention's priority through analysis of the epidemiological parameters of each country, a clear definition of the strategies and standards for use of the vaccines (vaccination schedule, age groups, number of doses, and vaccination techniques), and considerations related to the resources needed to ensure constant availability of the vaccines in the health services.
(The introduction of new or improved vaccines in national vaccination programs; should be preceded; by a determination of the intervention's priority) (considerations; related; to the resources) (Haemophilus Influenzae B Vaccine; needed; to ensure constant availability of the vaccines in the health services) Context(Haemophilus Influenzae B Vaccine needed,List([348, 949))):(Haemophilus Influenzae B Vaccine; needed to ensure; constant availability of the vaccines in the health services)
Haemophilus Influenzae B Vaccine needed,List([348, 949))
The introduction of new or improved vaccines in national vaccination programs considerations Haemophilus Influenzae B Vaccine Haemophilus Influenzae B Vaccine
should be preceded related needed needed to ensure
by a determination of the intervention's priority
to the resources
to ensure constant availability of the vaccines in the health services
constant availability of the vaccines in the health services